Galapagos NV
GLPG
$41.00
Share price
-0.87%
Change (1 day)
-25.66%
Change (1 year)
Categories
Market capitalization of Galapagos NV (GLPG)
Market cap: $2.76 Billion
As of June 2023 Galapagos NV has a market cap of $2.76 Billion. This makes Galapagos NV the world's 3312th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Galapagos NV from 2008 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $2.76 B | -5.44% |
| 2022 | $2.92 B | -20.02% |
| 2021 | $3.65 B | -43.58% |
| 2020 | $6.47 B | -52.07% |
| 2019 | $13.50 B | 169.16% |
| 2018 | $5.01 B | 4.51% |
| 2017 | $4.80 B | 61.16% |
| 2016 | $2.97 B | 20.89% |
| 2015 | $2.46 B | 331.92% |
| 2014 | $0.57 B | -8.94% |
| 2013 | $0.62 B | 10.91% |
| 2012 | $0.56 B | 58.44% |
| 2011 | $0.35 B | -16.16% |
| 2010 | $0.42 B | 66.9% |
| 2009 | $0.25 B | 148.04% |
| 2008 | $0.10 B |
End of Day market cap according to different sources
On Jun 1st, 2023 the market cap of Galapagos NV was reported to be:
$2.76 Billion
$2.76 Billion
$2.70 Billion
$2.69 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $401.60 B | 14,436.79% | 🇺🇸 USA |
 Abbott Laboratories ABT | $178.79 B | 6,371.89% | 🇺🇸 USA |
 AbbVie ABBV | $235.42 B | 8,421.63% | 🇺🇸 USA |
 Sanofi SNY | $126.03 B | 4,462.08% | 🇫🇷 France |
 Merck MRK | $281.47 B | 10,088.52% | 🇺🇸 USA |
 AstraZeneca AZN | $225.78 B | 8,072.49% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $69.32 B | 2,409.35% | 🇬🇧 UK |
 Fortress Biotech
FBIO | $73.2 M | -97.35% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.09 B | 193.06% | 🇮🇱 Israel |